Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...
The first new drug to treat Alzheimer’s in 17 years, Aduhelm (aducanumab), came out in 2021, but it’s already off the market. The research behind Aduhelm showed mixed results, and the ...
The 2024 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday by the US Department of Health and Human Services, highlighting federal approval ...
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...
Alzheimer’s drugs should be prescribed like statins ... This is “equally important” as any new drug, Prof Hardy stresses. Early diagnosis would greatly increase the chance of successful ...